CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
37 hedge funds and large institutions have $27.3M invested in Carisma Therapeutics in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
14% less funds holding
Funds holding: 43 → 37 (-6)
37% less capital invested
Capital invested by funds: $43.6M → $27.3M (-$16.2M)
55% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 11
Holders
37
Holding in Top 10
2
Calls
$1.95M
Puts
$240K
Top Buyers
| 1 | +$328K | |
| 2 | +$203K | |
| 3 | +$184K | |
| 4 |
BlackRock
New York
|
+$83.2K |
| 5 |
MTIM
Marathon Trading Investment Management
Radnor,
Pennsylvania
|
+$59K |
Top Sellers
| 1 | -$3.95M | |
| 2 | -$1.96M | |
| 3 | -$1.88M | |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$300K |
| 5 |
VF
Virtu Financial
New York
|
-$194K |